Article

Health-related quality of life after radical cystectomy for bladder cancer in elderly patients with an ileal conduit, ureterocutaneostomy, or orthotopic urinary reservoir: a comparative questionnaire survey.

Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Acta medica Okayama (Impact Factor: 0.75). 09/2007; 61(4):199-203.
Source: PubMed

ABSTRACT To compare the health-related quality of life of elderly patients after radical cystectomy for bladder cancer in urinary diversion groups: ileal conduit, ureterocutaneostomy, or orthotopic urinary reservoir. The 109 participating elderly patients aged 75 or older completed self-reporting questionnaires: the QLQ-C30, and on satisfaction with urinary diversion methods. Fifty-six patients had undergone constructions for ileal conduit diversion, 31 for ureterocutaneostomy, and 22 for orthotopic urinary reservoir (OUR). The median follow-up period for each group was 4.0 years (range 0.3-11.2), 4.5 years (range 0.3-18.0), and 3.3 years (range 0.3-6.7), respectively. Regardless of the type of urinary diversion, the majority of patients reported having good overall quality of life, although with some problem of pain. No significant differences among urinary diversion subgroups were found in any quality of life area in the QLQ-C30 questionnaire. More patients in the OUR sub-group felt disappointment than those in the ileal conduit or cutaneostomy sub-groups. However, a questionnaire which asked which diversion method would be preferable showed a trend that more patients in the OUR subgroup would have chosen the same one. Health-related quality of life appeared relatively good in these 3 groups. Patient demands and expectations may be so different from the results that the details of each urinary diversion method should be explained thoroughly. OUR construction could be a candidate even for elderly patients.

0 Bookmarks
 · 
104 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aufgrund des demographischen Wandels wird die Inzidenz von Blasenkarzinomen zunehmen. Bei muskelinvasiven Tumoren ist die radikale Zystektomie durch Fortschritte im perioperativen Management auch beim älteren Patienten indiziert. Durch die ebenfalls altersabhängige Zunahme von Komorbiditäten stellt sich die Frage nach der optimalen Harnableitung für den Risikopatienten. Das Ileumconduit stellt dazu aufgrund seiner sicheren, erprobten und risikoarmen Anwendung den Goldstandard dar. Aufgrund der Darmbeteiligung weist es jedoch relevante Komplikationsrisiken für den Risikopatienten auf. Eine noch einfachere und sichere Alternative stellt die Harnleiterhautfistel dar, die jedoch zunächst hohe Stenosierungsraten aufwies. Neuere Daten weisen allerdings darauf hin, dass vergleichbar viele Patienten ohne Harnleiterstent auskommen wie beim Ileumconduit. Auch Untersuchungen zur Lebensqualität zeigen vergleichbare Ergebnisse. Aus diesem Grund sollte die häufig zurückhaltende Einstellung gegenüber der Harnleiterhautfistel bei Risikopatienten überdacht werden.
    Der Urologe 09/2012; 51(9). DOI:10.1007/s00120-012-2829-2 · 0.44 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate quality of life (QoL) and overall survival after radical cystectomy with cutaneous ureterostomies for advanced bladder cancer in elderly patients with high surgical risk. 58 patients, over74 years of age (mean age 80,6±4,3) with locally advanced bladder cancer (group A), underwent radical cystectomy and ureterocutaneous diversion. Patients completed the EORTC QLQC30 before and six months after surgery to assess functional, clinical and QoL outcomes. The same evaluation was carried out in a control group (group B) of 29 patients (mean age 82,3±3,8 years), who had refused cystectomy. Questionnaires were also administered to patients of both groups who survived at 20 months and 5 years. All patients presented an ASA score ≥3. Mean hospital stay was 15.1 days (±4.8) in group A and 23.5 days (±4.1) in Group B for frequent hospitalizations. No intraoperative complications occurred in group A. Postoperative morbidity were defined and classified according to the Clavien score system. Postoperative overall survival evaluated within 6 months in group A was 97% versus 79% in group B (p<0.001). Relation between two groups at 6 months for Qol, functional and symptomatic items investigated showed in group A a statistically significant improvement for all parameters (p<0,001). This advantage for patients belonging to group A still resulted evident at 20 months and 5 years. Short-term and 20 months overall survival resulted statistically significant in favour of group A (p<0.001). Radical cystectomy with cutaneous ureterostomy represents a valid alternative in elderly patients with invasive bladder cancer and high operative risk. Comparison between two groups showed a statistically significant difference for almost all the Qol related parameters and for short and medium term overall survival.
    Cirugía Española 09/2013; DOI:10.1016/j.ciresp.2013.03.012 · 0.87 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective To conduct a prospective comparison of quality-of-life (QoL) outcomes in patients who underwent ileal conduit (IC) urinary diversion with those who underwent orthotopic neobladder (ONB) reconstruction after radical cystectomy for invasive bladder cancers. Patients and Methods Between January 2007 and December 2012, 227 patients underwent radical cystectomy and either IC urinary diversion or ONB (sigmoid or ileal) reconstruction.Contraindications for ON were impaired renal function (serum creatinine >2 mg/dL), chronic inflammatory bowel disease, previous bowel resection and tumour involvement at the bladder neck/prostatic urethra. Patients who did not have these contraindications chose to undergo either IC or ONB reconstruction, after impartial counselling.Baseline characteristics, including demographic profile, body mass index, comorbidities, histopathology of the cystoprostatectomy (with lymph nodes) specimen, pathological tumour stage, postoperative complications, adjuvant therapy and relapse, were recorded and compared.The European Organization for Research and Treatment of Cancer QoL questionnaire C30 version 3 was used to analyse QoL before surgery and 6, 12 and 18 months after surgery. ResultsOf the 227 patients, 28 patients in the IC group and 35 in the ONB group were excluded. The final analysis included 80 patients in the IC and 84 in the ONB group.None of the baseline characteristics were significantly different between the groups, except for age, but none of the baseline QoL variables were found to be correlated with age.In the preoperative phase, there were no significant differences in any of the QoL domains between the IC or the ONB groups. At 6, 12 and 18 months in the postoperative period, physical functioning (P < 0.001, P < 0.001 and P = 0.001, respectively), role functioning (P = 0.01, P = 0.01 and P = 0.003, respectively), social functioning (P = 0.01, P = 0.01 and P = 0.01, respectively) and global health status/QoL (P < 0.001, P < 0.001 and P = 0.002, respectively) were better in patients in the ONB group than in those in the IC group and the differences were significant.The financial burden related to bladder cancer treatment was significantly lower in the ONB group than in the IC group at 6, 12 and 18 months of follow-up (P = 0.05, P = 0.05 and P = 0.005, respectively) ConclusionsONB is better than IC in terms of physical functioning, role functioning, social functioning, global health status/QoL and financial expenditure.ONB reconstruction provides better QoL outcomes than does IC urinary diversion.
    BJU International 12/2013; 113(5). DOI:10.1111/bju.12440 · 3.13 Impact Factor

Full-text (2 Sources)

Download
33 Downloads
Available from
Jun 1, 2014